- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02507141
Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
March 12, 2026 updated by: Memorial Sloan Kettering Cancer Center
The purpose of this study is to get images (pictures) of oral lesions, which occur inside the mouth, before the patient's surgery using a special camera.
These pictures will be used in our research to evaluate a new technology that uses a laser and takes pictures of the microscopic structure of tissue.
The technology is called "reflectance confocal microscopy."
We would like to compare what the camera sees to biopsies (pathology) of the same area.
We will evaluate the pictures obtained from the patient to determine whether this technology may be useful in the future.
We hope this technology can be used as a tool for early diagnosis of oral cancers and for guiding surgery.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
140
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Snehal Patel, MD
- Phone Number: 212-639-3412
Study Contact Backup
- Name: Milind Rajadhyaksha, PhD
- Phone Number: 646-888-6243
Study Locations
-
-
New Jersey
-
Basking Ridge, New Jersey, United States
- Recruiting
- Memorial Sloan Kettering Basking Ridge (Consent Only)
-
Contact:
- Snehal Patel, MD
- Phone Number: 212-639-3412
-
Middletown, New Jersey, United States, 07748
- Recruiting
- Memorial Sloan Kettering Monmouth (Consent Only)
-
Contact:
- Snehal Patel, MD
- Phone Number: 212-639-3412
-
-
New York
-
Harrison, New York, United States, 10604
- Recruiting
- Memorial Sloan Kettering West Harrison (consent only)
-
Contact:
- Snehal Patel, MD
- Phone Number: 212-639-3412
-
New York, New York, United States, 10065
- Recruiting
- Memorial Sloan Kettering Cancer Center
-
Contact:
- Snehal Patel, MD
- Phone Number: 212-639-3412
-
Contact:
- Milind Rajadhyaksha, PhD
- Phone Number: 646-888-6243
-
Principal Investigator:
- Snehal Patel, MD
-
Uniondale, New York, United States, 11553
- Recruiting
- Memorial Sloan Kettering Nassau (Consent Only)
-
Contact:
- Snehal Patel, MD
- Phone Number: 212-639-3412
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Potential research subjects in the Head and Neck Service will be identified by a member of the patient's treatment team, the protocol investigator, or a member of the research team at Memorial Sloan Kettering Cancer Center (MSK).
Description
Inclusion Criteria:
- Patients with biopsy-proven oral SCC who are scheduled to undergo surgery in the MSK Head and Neck Service.
- Ability to sign informed consent.
- Age ≥ 18 years.
Exclusion Criteria:
- Cancer located on a site that may not be convenient or accessible for imaging with the current version of the RCM device (gingivobuccal region, back of the oral cavity, back of the tongue, floor of the mouth, deep under the tongue, etc.).
- Inability to give informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
SCC of the oral cavity scheduled for surgery
The patients will be imaged for testing the feasibility of intra-oral imaging.
Images will be compared to and evaluated against the corresponding pathology that is routinely prepared during surgery.
|
Reflectance Confocal Microscopy imaging will be performed during surgery.
The imaging procedure is expected to last no more than 15-20 minutes.
The approach will be essentially similar to the imaging of skin cancer on patients, which is routinely performed in our Dermatology Service.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reflectance Confocal Microscopy (RCM) images
Time Frame: 1 year
|
Each set of images and the corresponding pathology will be evaluated by the study pathologist for the presence or absence of oral SCC.
All images will be evaluated as a group.
First, the pathologist will review the RCM images for each imaging site and will determine the presence/absence of tumor.
Next, the pathologist will review the corresponding histopathologic material for the presence/absence of tumor.
If there is discordance in the evaluations, the pathologist will re-evaluate the RCM images with the corresponding pathology, in a side-by-side manner, to highlight any features that may assist in the RCM evaluation.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Snehal Patel, MD, Memorial Sloan Kettering Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 21, 2015
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Study Registration Dates
First Submitted
July 22, 2015
First Submitted That Met QC Criteria
July 22, 2015
First Posted (Estimated)
July 23, 2015
Study Record Updates
Last Update Posted (Actual)
March 16, 2026
Last Update Submitted That Met QC Criteria
March 12, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-128
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Cancer
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
Mayo ClinicCompletedCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
West China HospitalNot yet recruitingHead and Neck Cancer | Malignant Neoplasm | Advanced Head and Neck Carcinoma | Head &Amp; Neck Cancer
-
National Cancer Institute (NCI)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
Radboud University Medical CenterUnknown
-
Fondazione IRCCS Policlinico San Matteo di PaviaNestle Health Science; Akern SrlCompletedHead-neck CancerItaly
-
University of California, San FranciscoCompleted
-
Uppsala UniversityRegion Östergötland; Region Skane; Region Västerbotten; Swedish Cancer Society; S... and other collaboratorsNot yet recruitingHead and Neck Cancer | Head and Neck Cancer Squamous Cell CarcinomaSweden
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownAdvanced Head and Neck CancerChina
Clinical Trials on Reflectance Confocal Microscopy
-
Julie DawsonCompletedBasal Cell CarcinomaUnited Kingdom
-
Lucid, Inc.Memorial Sloan Kettering Cancer Center; University of Rochester; Loma Linda University and other collaboratorsCompletedMelanoma | Skin Cancer | Lentigo MalignaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH); University of RochesterCompletedMelanoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Non-Malignant Skin DisordersUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompletedMelanoma | Nevus | Lentigo | Basal Cell Carcinoma | Seborrheic Keratosis | Lentigo MalignaFrance
-
Technische Universität DresdenCompletedNon-melanoma Skin CancerGermany
-
Memorial Sloan Kettering Cancer CenterPhysical Sciences Inc.Active, not recruiting
-
Academisch Medisch Centrum - Universiteit van Amsterdam...The Netherlands Cancer InstituteCompletedCarcinoma, Basal CellNetherlands
-
Istanbul Training and Research HospitalBezmialem Vakif UniversityUnknown
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Mavig...Completed